Cargando…
Efficacy of erzhu jiedu recipe on hepatitis B cirrhosis with hyperalphafetoproteinemia: A randomized, double-blind, placebo-controlled clinical trial
BACKGROUND: Hepatitis B cirrhosis with hyperalphafetoproteinemia is the intermediate stage of liver cirrhosis progressing to hepatocellular carcinoma (HCC), there is no effective way to treat precancerous lesions of liver in modern medicine. In recent decades, clinical and experimental evidence show...
Autores principales: | Chen, Tian-Yang, Mai, Jing-Yin, Zhang, Ping, Xue, Jian-Hua, He, Sheng-Li, Xi, Jun, Chen, Jian-Jie, Cheng, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545361/ https://www.ncbi.nlm.nih.gov/pubmed/34559118 http://dx.doi.org/10.1097/MD.0000000000027231 |
Ejemplares similares
-
Erzhu Jiedu decoction ameliorates liver precancerous lesions in a rat model of liver cancer
por: Cheng, Yang, et al.
Publicado: (2020) -
A clinical study on the efficacy of Yiqi Huayu Jiedu decoction for reducing the risk of postoperative recurrence and metastasis of gastric cancer: Protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Wu, Cun-En, et al.
Publicado: (2020) -
A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)
por: Guo, Lijun, et al.
Publicado: (2020) -
A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease
por: Jin, Zhaohui, et al.
Publicado: (2020) -
Effects of Yangxinshi tablet on exercise tolerance in patients with coronary heart disease: A protocol of randomized, double-blind, placebo-controlled, and multi-center trial
por: Zhang, Sisi, et al.
Publicado: (2020)